RESUMEN
Melioidosis is an endemic disease in Southeast Asia and Oceania caused by the gram-negative bacillus Burkholderia pseudomallei. We studied 15 adult patients from Colombia with microbiologically diagnosed pulmonary melioidosis. We reviewed 15 chest X-rays and 10 chest computed tomography (CT) studies. Of the 15 patients, 87% met the criteria for acute infection and 13% met the criteria for chronic infection. The most common findings on chest X-rays were consolidation (86%), nodules (26%), and cavitation (20%). On CT studies, consolidation and nodules were observed in 90% of cases; the areas of consolidation were predominantly located in the basal and central zones in 60%. Areas of cavitation were observed in 50%, pleural effusion in 60%, and mediastinal lymph nodes in 30%. In patients with acute pulmonary melioidosis (n=8), the findings observed were nodules (100%), mixed pattern with nodules and consolidation (87%), pleural effusion (88%), and mediastinal lymph nodes (25%). The two patients with chronic pulmonary melioidosis both had cavitation. Acute lung infection with B. Pseudomallei has radiologic manifestations similar to those of pneumonia due to other causes. In areas where the disease is endemic, it is essential to include acute melioidosis in the differential diagnosis of pulmonary nodules and chronic melioidosis in the differential diagnosis of cavitated chronic lung lesions.
Asunto(s)
Burkholderia pseudomallei , Enfermedades Pulmonares , Melioidosis , Derrame Pleural , Neumonía , Tuberculosis Pleural , Adulto , Humanos , Enfermedades Pulmonares/diagnóstico por imagen , Melioidosis/diagnóstico por imagen , Melioidosis/epidemiología , Derrame Pleural/diagnóstico por imagen , Derrame Pleural/etiologíaRESUMEN
ABSTRACT: Recent cases suggest that melioidosis, an infection caused by Burkholderia pseudomallei, is an emerging infectious disease. Nurses have a key role in the care of patients with melioidosis. This article provides an overview of the epidemiology, clinical presentation, diagnosis, treatment, and prevention of melioidosis, and discusses unusual, non-travel-related cases of melioidosis.
Asunto(s)
Burkholderia pseudomallei , Enfermedades Transmisibles Emergentes , Melioidosis , Enfermedades Transmisibles Emergentes/epidemiología , Humanos , Melioidosis/diagnóstico , Melioidosis/tratamiento farmacológico , Melioidosis/epidemiologíaRESUMEN
Phylogenetic analysis of a clinical isolate associated with subclinical Burkholderia pseudomallei infection revealed probable exposure in the British Virgin Islands, where reported infections are limited. Clinicians should consider this geographic distribution when evaluating possible infection among persons with compatible travel history.
Asunto(s)
Burkholderia pseudomallei , Melioidosis , Islas Vírgenes Británicas , Burkholderia pseudomallei/genética , Humanos , Melioidosis/diagnóstico , Melioidosis/epidemiología , Filogenia , ViajeRESUMEN
Burkholderia pseudomallei is a Gram-negative bacterium that causes the sapronotic disease melioidosis. An outbreak in 2003 in the state of Ceara, Brazil, resulted in subsequent surveillance and environmental sampling which led to the recognition of B. pseudomallei as an endemic pathogen in that area. From 2003 to 2015, 24 clinical and 12 environmental isolates were collected across Ceara along with one from the state of Alagoas. Using next-generation sequencing, multilocus sequence typing, and single nucleotide polymorphism analysis, we characterized the genomic diversity of this collection to better understand the population structure of B. pseudomallei associated with Ceara. We found that the isolates in this collection form a distinct subclade compared to other examples from the Western Hemisphere. Substantial genetic diversity among the clinical and environmental isolates was observed, with 14 sequence types (STs) identified among the 37 isolates. Of the 31,594 core single-nucleotide polymorphisms (SNPs) identified, a high proportion (59%) were due to recombination. Because recombination events do not follow a molecular clock, the observation of high occurrence underscores the importance of identifying and removing recombination SNPs prior to evolutionary reconstructions and inferences in public health responses to B. pseudomallei outbreaks. Our results suggest long-term B. pseudomallei prevalence in this recently recognized region of melioidosis endemicity.IMPORTANCEB. pseudomallei causes significant morbidity and mortality, but its geographic prevalence and genetic diversity are not well characterized, especially in the Western Hemisphere. A better understanding of the genetic relationships among clinical and environmental isolates will improve knowledge of the population structure of this bacterium as well as the ability to conduct epidemiological investigations of cases of melioidosis.
Asunto(s)
Burkholderia pseudomallei/clasificación , Burkholderia pseudomallei/genética , Variación Genética , Genoma Bacteriano , Técnicas de Tipificación Bacteriana , Brasil/epidemiología , ADN Bacteriano/genética , Brotes de Enfermedades/estadística & datos numéricos , Genómica/métodos , Genotipo , Humanos , Masculino , Melioidosis/epidemiología , Melioidosis/microbiología , Filogenia , Análisis de Secuencia de ADNRESUMEN
We report an analysis of the genomic diversity of isolates of Burkholderia pseudomallei, the cause of melioidosis, recovered in Colombia from routine surveillance during 2016-2017. B. pseudomallei appears genetically diverse, suggesting it is well established and has spread across the region.
Asunto(s)
Burkholderia pseudomallei , Melioidosis , Burkholderia pseudomallei/genética , Colombia/epidemiología , Genómica , Humanos , Melioidosis/epidemiología , Tipificación de Secuencias MultilocusRESUMEN
The distribution of Burkholderia pseudomallei in the Caribbean is poorly understood. We isolated B. pseudomallei from US Virgin Islands soil. The soil isolate was genetically similar to other isolates from the Caribbean, suggesting that B. pseudomallei might have been introduced to the islands multiple times through severe weather events.
Asunto(s)
Burkholderia pseudomallei , Melioidosis , Microbiología del Suelo , Burkholderia pseudomallei/genética , Humanos , Islas , Melioidosis/epidemiología , Filogenia , Islas Virgenes de los Estados UnidosRESUMEN
Burkholderia pseudomallei is an emerging pathogen in the Americas. Cases of mother-to-child transmission of B. pseudomallei are rare and probably occur by placental or perinatal infection. We report the first case of native gestational and neonatal melioidosis in the Western hemisphere. The isolated strains in the mother and newborn were confirmed by whole-genome sequencing and identified as a novel sequence type ST1748. The comparison of both genomes revealed a nucleotide similarity of 100%. Melioidosis should be considered within the differential diagnosis of febrile illness or pneumonia in pregnant women and newborns from endemic areas of the Americas.
Asunto(s)
Transmisión Vertical de Enfermedad Infecciosa , Melioidosis/diagnóstico , Melioidosis/transmisión , Antibacterianos , Burkholderia pseudomallei/genética , Burkholderia pseudomallei/aislamiento & purificación , Colombia/epidemiología , Femenino , Genoma Bacteriano , Humanos , Recién Nacido , Melioidosis/tratamiento farmacológico , Melioidosis/epidemiología , Embarazo , Adulto JovenRESUMEN
Melioidosis is an infection caused by Burkholderia pseudomallei. Most cases occur in Southeast Asia and northern Australia; <100 cases have been reported in the Americas. We conducted a retrospective study and identified 12 melioidosis cases in Panama during 2007-2017, suggesting possible endemicity and increased need for surveillance.
Asunto(s)
Melioidosis/epidemiología , Adulto , Anciano , Femenino , Geografía Médica , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
We report 2 cases of melioidosis in women with diabetes admitted to an emergency department in the US Virgin Islands during October 2017. These cases emerged after Hurricanes Irma and Maria and did not have a definitively identified source. Poor outcomes were observed when septicemia and pulmonary involvement were present.
Asunto(s)
Tormentas Ciclónicas , Melioidosis/epidemiología , Desastres Naturales , Anciano de 80 o más Años , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Burkholderia pseudomallei/efectos de los fármacos , Femenino , Humanos , Melioidosis/diagnóstico , Melioidosis/tratamiento farmacológico , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Combinación Trimetoprim y Sulfametoxazol/uso terapéutico , Islas Virgenes de los Estados Unidos/epidemiologíaRESUMEN
Melioidosis is an infectious disease caused by Burkholderia pseudomallei whose clinical diagnosis can be difficult due not only to its varied clinical presentation but also to the difficulties in the microbiological diagnosis.Thus, it may be necessary to use molecular techniques for its proper identification once it is suspected. There are few antibiotics available for the treatment of this disease, which must be used over a long period of time. Although it is known to be endemic in Thailand, Malaysia, Singapore, Vietnam, and Australia, in Colombia there are few reported cases. We describe a case of melioidosis in the northern region of Colombia. Additionally, we review its clinical characteristics and treatment and we describe the local epidemiology of this disease.
La melioidosis es una enfermedad infecciosa causada por Burkholderia pseudomallei cuyo diagnóstico clínico puede ser difícil debido a su variada presentación clínica y a las dificultades del diagnóstico microbiológico, por lo cual pueden requerirse técnicas moleculares para su adecuada identificación una vez se sospecha su presencia. Son pocos los antibióticos disponibles para el tratamiento de esta enfermedad y, además, deben usarse durante un tiempo prolongado. Aunque se conoce por ser endémica en Tailandia, Malasia, Singapur, Vietnam y Australia, en Colombia se han reportado algunos pocos casos. Se presenta un caso de melioidosis en la región norte de Colombia, se hace una revisión de las características clínicas y el tratamiento, y se describe la epidemiología local de esta enfermedad.
Asunto(s)
Melioidosis/epidemiología , Amputación Quirúrgica , Antibacterianos/uso terapéutico , Burkholderia pseudomallei/aislamiento & purificación , Colombia/epidemiología , Diabetes Mellitus Tipo 2/complicaciones , Enfermedades del Pie/cirugía , Humanos , Huésped Inmunocomprometido , Fallo Renal Crónico/complicaciones , Masculino , Melioidosis/diagnóstico , Melioidosis/tratamiento farmacológico , Persona de Mediana Edad , Cooperación del Paciente , Recurrencia , Ribotipificación , Dedos del Pie/microbiología , Dedos del Pie/cirugía , Infecciones Urinarias/diagnóstico , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/microbiologíaRESUMEN
Resumen La melioidosis es una enfermedad infecciosa causada por Burkholderia pseudomallei cuyo diagnóstico clínico puede ser difícil debido a su variada presentación clínica y a las dificultades del diagnóstico microbiológico, por lo cual pueden requerirse técnicas moleculares para su adecuada identificación una vez se sospecha su presencia. Son pocos los antibióticos disponibles para el tratamiento de esta enfermedad y, además, deben usarse durante un tiempo prolongado. Aunque se conoce por ser endémica en Tailandia, Malasia, Singapur, Vietnam y Australia, en Colombia se han reportado algunos pocos casos. Se presenta un caso de melioidosis en la región norte de Colombia, se hace una revisión de las características clínicas y el tratamiento, y se describe la epidemiología local de esta enfermedad.
Abstract Melioidosis is an infectious disease caused by Burkholderia pseudomallei whose clinical diagnosis can be difficult due not only to its varied clinical presentation but also to the difficulties in the microbiological diagnosis.Thus, it may be necessary to use molecular techniques for its proper identification once it is suspected. There are few antibiotics available for the treatment of this disease, which must be used over a long period of time. Although it is known to be endemic in Thailand, Malaysia, Singapore, Vietnam, and Australia, in Colombia there are few reported cases. We describe a case of melioidosis in the northern region of Colombia. Additionally, we review its clinical characteristics and treatment and we describe the local epidemiology of this disease.
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Melioidosis/epidemiología , Recurrencia , Infecciones Urinarias/diagnóstico , Infecciones Urinarias/microbiología , Infecciones Urinarias/tratamiento farmacológico , Dedos del Pie/cirugía , Dedos del Pie/microbiología , Cooperación del Paciente , Burkholderia pseudomallei/aislamiento & purificación , Huésped Inmunocomprometido , Colombia/epidemiología , Ribotipificación , Diabetes Mellitus Tipo 2/complicaciones , Enfermedades del Pie/cirugía , Amputación Quirúrgica , Fallo Renal Crónico/complicaciones , Melioidosis/diagnóstico , Melioidosis/tratamiento farmacológico , Antibacterianos/uso terapéuticoRESUMEN
Burkholderia pseudomallei, the etiological agent of melioidosis, has been hypothesized to be endemic throughout the Caribbean, including the impoverished nation of Haiti. However, because of the protean clinical manifestations, presence of asymptomatic infections, and limited medical diagnostic capacity, the identification of active melioidosis cases remains challenging. A seroepidemiological study was conducted using a novel enzyme-linked immunosorbent assay (ELISA) to detect antibodies toward B. pseudomallei in the native population. The performance of an indirect ELISA with purified lipopolysaccharide (LPS) from B. pseudomallei was evaluated using serum collected from rhesus macaques exposed to aerosolized B. pseudomallei. After optimization, serum collected from asymptomatic population members (n = 756) was screened for polyvalent (immunoglobulin M [IgM]/ immunoglobulin G [IgG]/ immunoglobulin A) and monoclonal (IgG or IgM) immunoglobulins against B. pseudomallei LPS. The population seroprevalence was 11.5% (95% confidence interval [CI]: 9.2, 13.8) for polyvalent immunoglobulins, 9.8% (95% CI: 7.7, 11.9) for IgG, and 1.7% (95% CI: 0.8, 2.6%) for IgM. The seroprevalence was not significantly different by gender (P = 0.16), but increased significantly (P < 0.001) with age, yielding an estimated annual seroconversion rate of 1.05% (95% CI: 0.81, 1.3). The detection of both recent (IgM+) and previous (IgG+) exposure to B. pseudomallei provides serological evidence that melioidosis is endemic in Haiti.
Asunto(s)
Anticuerpos Antibacterianos/sangre , Burkholderia pseudomallei/inmunología , Melioidosis/epidemiología , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Animales , Infecciones Asintomáticas/epidemiología , Niño , Preescolar , Enfermedades Endémicas , Ensayo de Inmunoadsorción Enzimática , Femenino , Haití/epidemiología , Humanos , Lipopolisacáridos , Macaca mulatta/inmunología , Masculino , Melioidosis/inmunología , Persona de Mediana Edad , Estudios Seroepidemiológicos , Adulto JovenRESUMEN
Melioidosis, a disease caused by the pathogen Burkholderia pseudomallei, is a significant underreported endemic disease found in tropical countries worldwide. Recent studies have demonstrated that human melioidosis cases have been increasingly recognized in the Americas. Therefore, the first Scientific Reunion of Melioidosis in the Americas was organized in Colombia, with the participation of health authorities of 11 Latin American countries and the United States. This report summarizes the topics reviewed during the meeting, including how to identify human infections and properly diagnose them, with the goal of increasing recognition of the disease in the Americas.
Asunto(s)
Antibacterianos/uso terapéutico , Burkholderia pseudomallei/efectos de los fármacos , Melioidosis/diagnóstico , Melioidosis/tratamiento farmacológico , Américas/epidemiología , Antibacterianos/administración & dosificación , Bacteriemia/diagnóstico , Bacteriemia/epidemiología , Colombia , Humanos , Melioidosis/epidemiología , Viaje , Estados Unidos/epidemiologíaRESUMEN
Melioidosis is a bacterial infection caused by Burkholderia pseudomallei, a gram-negative saprophytic bacillus. Cases occur sporadically in the Americas with an increasing number of cases observed among people with no travel history to endemic countries. To better understand the incidence of the disease in the Americas, we reviewed the literature, including unpublished cases reported to the Centers for Disease Control and Prevention. Of 120 identified human cases, occurring between 1947 and June 2015, 95 cases (79%) were likely acquired in the Americas; the mortality rate was 39%. Burkholderia pseudomallei appears to be widespread in South, Central, and North America.
Asunto(s)
Melioidosis/epidemiología , Burkholderia pseudomallei , Región del Caribe/epidemiología , América Central/epidemiología , Humanos , Incidencia , América del Norte/epidemiología , América del Sur/epidemiologíaAsunto(s)
Antibacterianos/uso terapéutico , Burkholderia pseudomallei/patogenicidad , Melioidosis/tratamiento farmacológico , Viaje , Antibacterianos/administración & dosificación , Burkholderia pseudomallei/genética , Femenino , Humanos , Melioidosis/epidemiología , Melioidosis/patología , México/epidemiología , Persona de Mediana Edad , Filogenia , Estados Unidos/epidemiologíaRESUMEN
PROBLEM/CONDITION: Melioidosis is an infection caused by the Gram-negative bacillus Burkholderia pseudomallei, which is naturally found in water and soil in areas endemic for melioidosis. Infection can be severe and sometimes fatal. The federal select agent program designates B. pseudomallei as a Tier 1 overlap select agent, which can affect both humans and animals. Identification of B. pseudomallei and all occupational exposures must be reported to the Federal Select Agent Program immediately (i.e., within 24 hours), whereas states are not required to notify CDC's Bacterial Special Pathogens Branch (BSPB) of human infections. PERIOD COVERED: 2008-2013. DESCRIPTION OF SYSTEM: The passive surveillance system includes reports of suspected (human and animal) melioidosis cases and reports of incidents of possible occupational exposures. Reporting of suspected cases to BSPB is voluntary. BSPB receives reports of occupational exposure in the context of a request for technical consultation (so that the system does not include the full complement of the mandatory and confidential reporting to the Federal Select Agent Program). Reporting sources include state health departments, medical facilities, microbiologic laboratories, or research facilities. Melioidosis cases are classified using the standard case definition adopted by the Council of State and Territorial Epidemiologists in 2011. In follow up to reports of occupational exposures, CDC often provides technical assistance to state health departments to identify all persons with possible exposures, define level of risk, and provide recommendations for postexposure prophylaxis and health monitoring of exposed persons. RESULTS: During 2008-2013, BSPB provided technical assistance to 20 U.S. states and Puerto Rico involving 37 confirmed cases of melioidosis (34 human cases and three animal cases). Among those with documented travel history, the majority of reported cases (64%) occurred among persons with a documented travel history to areas endemic for melioidosis. Two persons did not report any travel outside of the United States. Separately, six incidents of possible occupational exposure involving research activities also were reported to BSPB, for which two incidents involved occupational exposures and no human infections occurred. Technical assistance was not required for these incidents because of risk-level (low or none) and appropriate onsite occupational safety response. Of the 261 persons at risk for occupational exposure to B. pseudomallei while performing laboratory diagnostics, 43 (16%) persons had high-risk exposures, 130 (50%) persons had low-risk exposures, and 88 (34%) persons were classified as having undetermined or unknown risk. INTERPRETATION: A small number of U.S. cases of melioidosis have been reported among persons with no travel history outside of the United States, whereas the majority of cases have occurred in persons with a travel history to areas endemic for melioidosis. If the number of travelers continues to increase in countries where the disease is endemic, the likelihood of identifying imported melioidosis cases in the United States might also increase. PUBLIC HEALTH ACTIONS: Reporting of melioidosis cases can improve the ability to monitor the incidence and prevalence of the disease in the United States. To improve prevention and control of melioidosis, CDC recommends that (1) physicians consider melioidosis in the differential diagnosis of patients with acute febrile illnesses, risk factors for melioidosis, and compatible travel or exposure history; (2) personnel at risk for occupational exposure (e.g., laboratory workers or researchers) follow proper safety practices, which includes using appropriate personal protective equipment when working with unknown pathogens; and (3) all possible occupational exposures to B. pseudomallei be reported voluntarily to BSPB.
Asunto(s)
Burkholderia pseudomallei/aislamiento & purificación , Melioidosis/epidemiología , Melioidosis/veterinaria , Enfermedades Profesionales/epidemiología , Exposición Profesional/estadística & datos numéricos , Vigilancia de la Población , Investigadores , Adulto , Anciano , Anciano de 80 o más Años , Animales , Centers for Disease Control and Prevention, U.S. , Niño , Femenino , Humanos , Iguanas/microbiología , Macaca/microbiología , Masculino , Persona de Mediana Edad , Exposición Profesional/efectos adversos , Puerto Rico/epidemiología , Investigadores/estadística & datos numéricos , Medición de Riesgo , Factores de Riesgo , Viaje , Estados Unidos/epidemiología , Adulto JovenRESUMEN
BACKGROUND: Melioidosis is endemic in Malaysia, the southwest of Thailand, and northern Australia. The incidence in Thailand is 4.4/1000000 inhabitants, where it causes 19% of community-acquired pneumonia (CAP) and 20% of bacteremic pneumonia, and the mortality is 50%. Sporadic cases have been described in Central and South America. The objective of this study was to describe the clinical and epidemiological features and ecological characteristics of melioidosis in Antioquia, Colombia. METHODS: This is a case series description. RESULTS: Seven cases were identified. Burkholderia pseudomallei was isolated from peripheral blood, pleural fluid, and urine and was identified by the automated system VITEK 2 (bioMérieux) and API 20NE biochemical kit. Five of the cases had a bacteremic form with shock and pulmonary compromise and two of these patients died. The non-bacteremic melioidosis cases had genitourinary, abdominal, and osteoarticular compromise. All patients had comorbidities and lived in rural hot and humid areas in the west central region of Colombia (Antioquia). Diabetes mellitus, renal insufficiency, and other chronic diseases are important risk factors for the development of severe forms. CONCLUSIONS: The cases presented here are similar to those occurring in endemic areas regarding comorbidity, risk factors, clinical presentation, and environmental conditions. It is necessary to establish whether melioidosis is an endemic and under-diagnosed disease or an emerging disease in Colombia.
Asunto(s)
Burkholderia pseudomallei/aislamiento & purificación , Infecciones Comunitarias Adquiridas/epidemiología , Enfermedades Endémicas , Melioidosis/diagnóstico , Melioidosis/epidemiología , Adulto , Anciano , Bacteriemia/epidemiología , Niño , Colombia/epidemiología , Comorbilidad , Diabetes Mellitus/epidemiología , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Insuficiencia Renal/epidemiología , Factores de Riesgo , América del SurRESUMEN
OBJECTIVE: There are limited sources describing the global burden of emerging diseases. A review of human melioidosis reported by ProMED was performed and the reliability of the data retrieved assessed in comparison to published reports. The effectiveness of ProMED was evaluated as a source of epidemiological data by focusing on melioidosis. METHODS: Using the keyword 'melioidosis' in the ProMED search engine, all of the information from the reports and collected data was reviewed using a structured form, including the year, country, gender, occupation, number of infected individuals, and number of fatal cases. RESULTS: One hundred and twenty-four entries reported between January 1995 and October 2014 were identified. A total of 4630 cases were reported, with death reported in 505 cases, suggesting a misleadingly low overall case fatality rate (CFR) of 11%. Of 20 cases for which the gender was reported, 12 (60%) were male. Most of the cases were reported from Australia, Thailand, Singapore, Vietnam, and Malaysia, with sporadic reports from other countries. CONCLUSIONS: Internet-based reporting systems such as ProMED are useful to gather information and synthesize knowledge on emerging infections. Although certain areas need to be improved, ProMED provided good information about melioidosis.